Skip to main content
Equibles

Invesco Ltd.

Position in PGEN — Precigen, Inc.

CIK 914208 Atlanta, GA
Back to PGEN Full portfolio

Position in PGEN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$851,391
+$416,118 QoQ
Shares Held
149,367
+32.8% QoQ
Ownership
0.042%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#70
of 210 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 96% None 4%

Common Shares in PGEN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Invesco Ltd. holds $14,420,023,301 across 296 Biotechnology names. PGEN ranks #158 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 8,043,052 $3,995,225,212
2 REGN
Regeneron Pharmaceuticals, Inc.
 3,940,665 $2,457,162,245
3 ALNY
Alnylam Pharmaceuticals, Inc.
 3,754,318 $1,130,162,341
4 INCY
Incyte Corp
 4,080,461 $462,561,050
5 ARGX
Argenx SE
 443,990 $411,920,598
6 AXSM
Axsome Therapeutics, Inc.
 1,671,684 $409,178,086
7 MRNA
Moderna, Inc.
 5,780,299 $404,794,337
8 LGND
Ligand Pharmaceuticals Inc
 1,201,644 $379,827,645

All Filings in PGEN

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $851,391 149,367
2026-03-31 $435,273 112,474
2025-12-31 $1,562,407 373,782
2025-09-30 $350,577 106,559
2025-06-30 $89,395 62,955
2025-03-31 $65,269 43,806
2024-12-31 $52,982 47,307
2024-09-30 $39,202 41,267
2024-06-30 $65,625 41,535
2024-03-31 $64,686 44,612
2023-12-31 $59,606 44,483
2023-09-30 $44,763 31,524
2023-06-30 $36,009 31,313
2023-03-31 $138,935 131,072
2022-12-31 $64,624 42,517
2022-09-30 $98,222 46,332
2022-06-30 $56,802 42,391
2022-03-31 $94,048 44,573
2021-12-31 $161,947 43,652
2021-09-30 $249,988 50,098
2021-06-30 $7,880,814 1,208,714
2021-03-31 $6,548,490 950,434
2020-12-31 $12,615,236 1,236,788
2020-09-30 $173,893 49,684
2020-06-30 $4,208,829 843,453
2020-03-31 $163,611 48,121